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Abstract
Purpose The therapy with mandibular advancement devices
(MADs) represents a treatment option for patients with ob-
structive sleep apnea (OSA). The literature does not provide
evidence regarding the most effective mandibular advance-
ment; therefore, the aim of this systematic review with meta-
regression was to investigate the effectiveness of different
mandibular advancement amounts in reducing apnea-
hypopnea index (AHI) in OSA patients.
Methods An electronic search was performed in MEDLINE,
Cochrane Database, Google Scholar Beta, ISI Web of Knowl-
edge, Scopus, and LILACS to select randomized controlled
trials (RCTs) investigating the efficacy of MADs in reducing
AHI in adult OSA patients. Inclusion criteria were the diag-
nosis of OSA and success evaluation performed with a
polysomnography, follow-up of maximum 12 months, and
protrusion amount reported as a percentage of the maximum
mandibular advancement. The quality of evidence was evalu-
ated using the Grading of Recommendations Assessment, De-
velopment and Evaluation (GRADE) methodology. The suc-
cess rate of each study was computed: [(mean AHI at
baseline-mean AHI after treatment)/mean AHI at baseline].
Results Thirteen RCTs performing advancements from 50 to
89 % of maximum mandibular protrusion were included. The
meta-regression analysis showed that advancement amounts
higher than 50 % do not significantly influence the success
rate (Q=0.373, p=0.541). According to the GRADE score
system, the quality of evidence resulted to be moderate.
Conclusion The AHI improvement resulted to be not propor-
tional to the mandibular advancement increase. It is plausible
that the success of the therapy is influenced by a combination
of variables that need closer study.
Keywords Obstructive sleep apnea .Mandibular
advancement device . Sleep disorders . Sleep disordered
breathing . Temporomandibular disorders
Introduction
Obstructive sleep apnea (OSA) syndrome is a common sleep-
related breathing disorder affecting 2–4 % of middle-aged
men and women [1–3]. It is characterized by the repetitive
obstruction of the upper airway during sleep, which deter-
mines snoring, sleep fragmentation and is associated to sys-
temic hypertension, metabolic syndrome, heart failure,
neurocognitive impairment [4, 5] and with a significant in-
creased risk of mortality [6, 7].
Forward repositioning of the mandible increases the upper
airway volume, widens the lateral dimension of the
velopharynx, it stretches tongue muscles counteracting
tongue’s retrolapse during sleep, and it moves the hyoid bone
anteriorly and stabilizes epiglottis and soft palate preventing
the posterior rotation of the jaw [8–10]. The therapy with a
mandibular advancement device (MAD) represents a treat-
ment option to obtain this anterior jaw repositioning; it is
indicated in patients affected by mild to moderate OSA and
in the ones with severe OSA who refuse continuous positive
airway pressure (CPAP) treatment or surgery [2, 11–14]. The
MAD therapy generally improves the Apnea Hypopnea Index
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(AHI) [2], the sleep quality, and also the work performances
[8, 12].
Despite many studies investigated the efficacy of the MAD
therapy, no consistent data are provided about the most effec-
tive mandibular protrusion amount: some authors suggest a
mild advancement [15, 16], others prefer a high protrusion
[17–19], and while others perform a progressive advancement
in order to avoid the masticatory side effects that the MAD
therapy brings about [15, 20].
Since a common advancement protocol is lacking [10], the
aim of the present systematic review with meta-regression anal-
ysis is to investigate which is the effectiveness of different man-
dibular protrusion amounts in reducing AHI in OSA patients.
Material and methods
The present systematic review follows the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
system [21].
To identify the studies to be considered for inclusion, de-
tailed search strategies were developed for the following elec-
tronic databases: MEDLINE, Cochrane Database of System-
atic Reviews, Google Scholar Beta, ISI Web of Knowledge,
Scopus, and LILACS. Also gray literature was searched in
order to find unpublished data. Manual search of selected
studies by looking at their references was conducted as well.
Studies from 1 January 1990 to 30 April 2015 were ana-
lyzed, without language restrictions.
The search strategy used for MEDLINE including the
MeSH and text words was (((Sleep Apnea, Obstructive
[Mesh]) OR (Sleep Apnea) OR (Sleep Apnoea)) OR (Sleep
breathing disorder OR sleep respiratory disorder))) AND
((Mandibular Advancement Device) OR (Mandibular ad-
vancement appliance)).
Only randomized controlled trials (RCTs) that investigated
the relationship between the MAD protrusion amount and the
improvement of the AHI were included in the present review.
Other inclusion criteria were the diagnosis of OSA performed
with a polysomnography (PSG) (AHI≥5) same as the evalu-
ation of the success of the therapy, adult patients (>18 years),
follow-up of maximum 12 months to limit the variation of the
BMI which could affect AHI’s results, and protrusion amount
reported as a percentage value of the maximum mandibular
protrusion.
Two researchers independently selected the articles
(M.L.B. and E.R.). Intra-examiner conflicts were resolved
by the discussion of each article to reach a consensus.
Data items and collection
The following data items were collected from each study in-
cluded: study design, sample size, mean age, mean BMI,
MADs’ protrusion amount, AHI at baseline, AHI after thera-
py, follow-up, and authors’ main conclusions.
Risk of bias in individual studies and across the studies
To document the methodological soundness of each article,
the Quality Assessment Tool for Quantitative Studies by Ef-
fective Public Health Practice Project (EPHPP) [22] was used.
To evaluate the risk of bias in individual studies, the Cochrane
Collaboration’s tool for assessing risk of bias in randomized
trials was used [23]. To evaluate the quality of body of evi-
dence, the Grading of Recommendations Assessment, Devel-
opment and Evaluation (GRADE) was performed [24].
Two assessors (F.B. and G.A.B.) independently performed
the quality evaluations; when in disagreement, a conjunct
evaluation was performed to reach a consensus.
The risk of bias across the studies was evaluated by means
of Egger’s test and Funnel plot; no information about
reporting bias is presented because our evaluations are not
based on raw data of individual studies.
Statistical tests of heterogeneity were carried out to assess
whether the observed variability in study results (effect sizes)
was greater than that expected to occur by chance. The het-
erogeneity among studies was assessed using a χ2-based Q
statistic test and I2 index; however, because of the moderate
insensitivity of the Q statistic, only an I2 index greater than
50 % was considered associated with a substantial heteroge-
neity among the studies. The tau2 was also calculated for the
heterogeneity assessment.
Definition for success rate
Success rate for each protrusion amount was calculated as
[(mean AHI at baseline - mean AHI after treatment)/mean
Fig. 1 Flow diagram of the search strategy (PRISMA)
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AHI at baseline], that is, the mean percentage of improving
where 1 represents total healing.
Methodology of synthesis of the results of the individual
studies
A fixed effect model was used if homogeneity was proved
(p>0.10); if homogeneity was rejected (p<0.10), a random
effects model was used to better aggregate the data [25].
Success rate and 95% confidence interval (CI) of each treat-
ed group within the studies were computed; regarding the stud-
ies comparing the efficacy of different MADs at the same ad-
vancement amount, the success rate was computed for each
group. In order to evaluate the effect of the advancement
amount on success rate, a meta-regression analysis was per-
formed. Calculations were carried out bymeans of Comprehen-
sive Meta-Analysis software (Biostat Inc, Englewood, NJ).
Results
From the 674 articles initially retrieved, 13 studies were in-
cluded for the qualitative analysis. Figure 1 reports the selec-
tion process and Table 1 describes the studies included.
Among these, one trial compared the effectiveness of 25, 50,
and 75 % of maximum mandibular protrusion [15] and two
studies compared the efficacy of 50 and 75 % [16, 17]; nine
studies performed only one advancement amount (50 [26], 70
[20], 74 [27], 75 [28–32], 83 [33], or 89 % [34]) in compar-
ison with other therapies or no treatment. Two studies [28, 33]
compared the two groups at the same protrusion amount wear-
ing different devices: the analysis computed those groups
separately.
Condition recordings and study treatments
Treatments were performed with different types of
MAD. Some studies fully described the appliance and
the way it produced mandibular protrusion [16, 17, 27,
29–31, 33, 34].
Few studies reported the assessment of the protrusion
amount: with a steel ruler [16] or with a bite fork (George
Gauge System [20, 27, 31, 34] or Projet bite forks [30]).
Ten papers described the type of PSG and the way it was
performed [16, 17, 20, 26–29, 31, 33, 34]. Few authors report-
ed the total sleep time of the registration night [28, 32].
Quality analysis and risk of bias in individual studies
The results of the EPHPP quality analysis are shown in
Table 2. Selection bias was weak in two studies [28,
31] because the authors did not report the way the par-
ticipants were enrolled in the study. Confounders (age,
gender, BMI, neck circumference, smoke, alcohol con-
sumption, and AHI at baseline) were not controlled in
four studies [16, 26, 31, 34].
In only one study, both assessors and participants were
blinded [27], in six studies assessors or participants were
blinded [15–17, 26, 30, 32], and six studies did not use
blinding for measurements [20, 28, 29, 31, 33, 34]. Regarding
withdrawals, one study [26] gained a moderate score because
the rate of patients that completed the follow-up was of only
60–79 %.
The risk of bias analysis resulted low or unclear for all
studies (Table 3). The main shortcomings are that allocation
concealment and sequence generation are not described in
most of the studies.
Table 2 Quality evaluation in individual studies (EPHPP)
Article Selection bias Study design Confounders Blinding Data collection
methods
Withdrawals and
drop-outs
Global
ratings
Bloch 2000 [28] Weak Strong Strong Weak Strong Strong Weak
Walker-Engstrom 2002 [26] Moderate Strong Weak Moderate Strong Moderate Moderate
Tan 2002 [29] Moderate Strong Strong Weak Strong Strong Moderate
Johnston 2002 [30] Moderate Strong Strong Moderate Strong Strong Strong
Tegelberg 2003 [16] Moderate Strong Weak Moderate Strong Strong Moderate
Walker-Engstrom 2003 [17] Moderate Strong Strong Moderate Strong Strong Strong
Blanco 2005 [31] Weak Strong Weak Weak Strong Strong Weak
Hoekema 2007 [34] Moderate Strong Weak Weak Strong Strong Weak
Petri 2008 [27] Moderate Strong Strong Strong Strong Strong Strong
Ghazal 2009 [33] Moderate Strong Moderate Weak Strong Strong Moderate
Deane 2009 [32] Moderate Strong Strong Moderate Strong Strong Strong
Campbell 2009 [20] Moderate Strong Moderate Weak Strong Strong Moderate
Aarab 2010 [15] Moderate Strong Strong Moderate Strong Strong Strong
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The GRADE scores are shown in Table 4. The reason for
lowering the quality of the evidence to the moderate score was
the indirectness.
Results of individual studies
Table 1 reports the results of individual studies. Aarab et al.
[15] compared the advancements of 0, 25, 50, and 75% of the
maximum protrusion with a cross over study design showing
that the advancements of 50 and 75 % were effective in re-
ducing AHI. Other two cross over studies [16, 17] compared
different protrusion amounts (50 and 75 %) using the same
MAD. Three studies compared different types of MAD at the
same protrusion amount [20, 28, 33]. Three authors compared
MADs with non-advanced appliances [27, 30, 31]. Two stud-
ies [29, 34] compared the efficacy of the MAD versus CPAP
in reducing AHI. In one study [26], MAD was compared with
uvulopalatopharyngoplasty.
Synthesis of results
One study [34] reported the AHI values as median and inter-
quartile ranges: in order to compute the success rate, the mean
values were obtained contacting the authors. Heterogeneity of
the groups was 8.7 % therefore a fixed effect model was used.
Figure 2 reports the success rates and confidence intervals of
each group included in the quantitative analysis. The meta-
regression analysis showed that the mandibular advancement
amount does not significantly influence the success rate
(Q=0.018, p=0.892) as reported in Fig. 3.
Risk of bias across studies
Concerning the publication bias, Funnel plot of healing im-
provement (success rate) against its standard error is reported
in Fig. 4; results of Egger’s test (intercept 0.467, p=0.623)
demonstrate no significant deviation of the intercept from the
symmetry, and consequently, studies with greater size are dis-
tributed near the mean and studies of less size are spread.
Discussion
The aim of the present systematic reviewwithmeta-regression
analysis was to investigate the effectiveness of different man-
dibular advancement amounts to treat OSA patients with the
MAD. The literature does not provide common guidelines: a
large number of studies reported the efficacy of different de-
vices without explaining the rationale to choose the advance-
ment amount.
Thirteen RCTs were included for the qualitative analysis
and resulted to be of a medium-high quality on average. The
meta-regression analysis was conducted to evaluate the effect
of different amounts of mandibular advancement on success
rate defined as the improvement of AHI after treatment
weighted on the AHI value at baseline. The results show that
the advancement amounts do not influence the success rate: in
fact, the regression line in the bubble plot remains almost flat,
without upward or downward trends (Fig. 3). The mean value
of the success rate among the analyzed studies is 62.3 %
(Fig. 2), and they include advancements from 25 to 89 % of
the maximum mandibular capacity. All the studies included
except one [15] investigated the efficacy of a protrusion
amount of 50 % or higher. The mandibular advancement of
50% is widely used as the minimum effective advancement to
start the MAD therapy, but this parameter has not been ade-
quately determined on the basis of comparisons with lower
mandibular advancements. In fact, the literature provides only
two studies that investigated the efficacy of mandibular ad-
vancements lower than 50% [15, 35]. What emerges from the
present analysis is that the success rate of the study with the
advancement of 25% is not the lowest registered. As shown in
Fig. 2, success rates lower than 50 % derive from investiga-
tions with mandibular advancements from 74 to 83 % [20, 27,
30, 33]. On the other hand, among the studies that registered a
success rate higher than 70 %, there is also one investigation
that performed an advancement of 50 % [26]. It is also impor-
tant to underline that in most of the analyzed studies the suc-
cess rate has wide confidence intervals (Fig. 2) suggesting a
high inter-individual variability in response to the MAD ther-
apy supporting the findings of a recent systematic-review
Table 4 Quality assessment and summary of findings across studies (GRADE)
Quality assessment Summary of findings
Number of studies
(Design)
Risk of bias Inconsistency Indirectness Imprecision Publication
bias
Number
of patients
Mean Success
rate [95 % CI]
Quality
Effectiveness of different advancements in reducing AHI
Outcome: Success rate
Thirteen (RCTs) Unclear/Low
RoB for most
of the studies
No inconsistency Serious indirectness
for most of
the studies
No serious
imprecision
No serious publication
bias
484 0.623
[0.562–0.678]
Moderate
RoB risk of bias
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[36]. The present results seem to be in contrast with the current
opinion that the more the mandible is stretched forward the
more the AHI improves [37].
The outcomes of the present meta-regression suggest that
the amount of mandibular protrusion could not be the unique
factor that influences the effectiveness of a MAD therapy, but
also other elements could contribute to determine the reaction
of a single patient to the treatment and a careful control of
predictive parameters would be crucial to personalize the
treatment.
To date, the data provided regarding possible predictive
parameters of the efficacy of MAD treatment are quite few
and inconclusive [38]. To the question of tailoring the treat-
ment according to the single patient’s characteristics, the video
sleep endoscopy may represent a useful answer since during
the investigation it could be possible to identify the effective
protrusion amount controlling the progressive improvement
of the airway patency [8, 11, 12].
It could be interesting to better investigate the possibility of
performing lower advancements in order to limit the side ef-
fects: the MAD forces the mandible in a forward and down-
ward position that elongates the fibers of jaw elevator muscles
and temporomandibular joint ligament causing a strain in
those muscles and in the retrodiscal tissues, that could induce
the onset of tenderness or pain in the temporomandibular
structures [39, 40]. As a consequence, a cautious approach
with a lower mandibular advancement could control these
events, considering also that the American Academy of Sleep
Medicine guidelines recognize the development of temporo-
mandibular disorders as the main reason for interrupting the
therapy with the MAD [41].
It is also important to consider that a significant intra-
individual night to night variability in AHI was demonstrated:
in a sample of 193 patients, Ahmadi and coworkers [42] reg-
istered a difference of AHI>5 between two consecutive PSGs
in 21 % of the subjects; White and colleagues registered a
difference of AHI>10 between the two consecutive PSGs in
the 35 % of their sample (n=26) [43]. To this regard, Aarab
and coworkers suggested to be cautious in diagnosing OSA on
the basis of a single PSG registration [44]. Consequently, fur-
ther methodologically sound clinical studies considering the
intra-individual AHI variability are needed.
The limitations of the present review are linked to the small
sample size of the studies. In addition, not all the included
Fig. 2 Forest plot of success rates in the included groups (correlation = success rate)
Fig. 3 Bubble plot of the relationship between success rate (reported as
Fisher’s Z) and mandibular advancement (the size of the bubbles is
proportional to the weight of the studies in the meta-regression)
Fig. 4 Funnel plot of the effect size of studies included against its
Standard Error
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studies controlled the confounding variables such as BMI,
neck circumference, and AHI at baseline, which could be
causally related to the outcome of interest.
The risk of bias of all the studies resulted low or unclear
(Table 3), and the EPHPP quality analysis showed that al-
though only RCTs were included, their quality resulted strong
in five studies, moderate in five, and weak in the other three.
The insufficient control of the possible confounders and the
lack of blinding negatively influenced the scores attributed to
the studies. Regarding the body of evidence quality assess-
ment (GRADE), the moderate score is due to the indirectness:
most of the studies aimed at comparing different therapies or
different devices at the same protrusion amount, but not the
efficacy of different mandibular advancements.
The present study revealed some weakness of the current
evidence; therefore, there is a need for further studies aimed at
detecting possible confounders able to influence the response
to the therapy and at comparing the efficacy of different man-
dibular protrusion amounts also lower than 50 %, in order to
verify the results of this meta-regression.
Since some authors suggest to use adjustable MADs that
allow to perform a progressive advancement and to manage
the possible symptoms during the titration [8, 14, 15, 17, 45]
and in light of the present results, it would be recommended to
careful titrate the advancement of the MAD starting with min-
imum protrusions in order to better individualize the therapy
and to induce an adaptation of the masticatory system.
Conclusions
There is small body of moderate quality evidence to suggest
that increasing the mandibular advancement does not produce
significant improvements in the success rate since there is a
high inter-individual variability in response to the MAD
therapy.
It would be cautious to begin the therapy addressing the
minimum effective mandibular advancement.
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